ERMARD

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, ERMARD mutation is significantly associated with the RNA expression of many other genes, with 3,146 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ERMARD-associated genes across cancer lineages are RNA5SP420, OR7E117P, and MARK3P3. Each is linked with ERMARD in more than 2 cancer types. Because this analysis shows association rather than direction, both ERMARD-to-partner and partner-to-ERMARD results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP420 grouped by ERMARD-low versus ERMARD-high in LUSC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ERMARD→partner) and Y-score (partner→ERMARD) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUSCRNA5SP420 →+0.399+4.309.003.00733
SKCMOR7E117P →+0.022+3.356<.001.00532
SKCMMARK3P3 →+0.063+2.414.008.00632
LUADMIR4472-1 →+0.459+4.554<.001.00932
LUADSPRING1P1 →+0.103+6.108<.001.00132
CESCTRAJ12 →+0.852+4.193<.001.00932
Each partner links to its Q-omics profile. Showing the 6 strongest of 3,146 associations by consensus.

RNA5SP420 by ERMARD expression — LUSC

Box plot of RNA5SP420 in ERMARD-low vs ERMARD-high samples in LUSC.

Explore this box plot interactively →

Exploration